PGP and non-small cell lung carcinoma: Rosmarinic acid could reverse the cisplatin resistance by inhibiting the expression of P-gp, MDR1, and MAPK pathways and plays a key role in the treatment of non-small cell lung cancer (NSCLC) (Liao et al., 2020).